Serial CEA levels in colorectal carcinoma on adjuvant immuno (chemo) therapy

✍ Scribed by L. Carluccio; S. Colizza; A. Costantino; M. Dipaola; N. Sopranzi

• Publisher: John Wiley and Sons
• Year: 1978
• Tongue: English
• Weight: 413 KB
• Volume: 10
• Category: Article
• ISSN: 0022-4790
• DOI: 10.1002/jso.2930100606

✦ Synopsis

Abstract

Serial CEA levels have been studied preoperatively, and one day, 10–15 days, four months, and eight months after surgery in a group of colon cancer patients who started soon after surgery a protocol of adjuvant immuno(chemo)therapy with Levamisole® and BCG®. Results showed a decrease of mean values of plasma CEA levels from preoperatively to four months after surgery, while eight months after surgery a slight increase was noted. Some of the patients in whom disease recurred showed persistent high levels of CEA, while one patient was consistently a false‐negative notwithstanding a bone recurrence. While the prognostic value of serial CEA determinations is confirmed, the possibility of restarting (or intensifying) a protocol of adjuvant immunochemotherapy given high CEA levels and a negative clinical picture is discussed.